Mesa Laboratories (MLAB) Competitors $104.51 +0.16 (+0.15%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$104.51 0.00 (0.00%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLAB vs. FARO, DAKT, VPG, COHR, BMI, ITRI, CGNX, OSIS, SENS, and HURCShould you be buying Mesa Laboratories stock or one of its competitors? The main competitors of Mesa Laboratories include FARO Technologies (FARO), Daktronics (DAKT), Vishay Precision Group (VPG), Coherent (COHR), Badger Meter (BMI), Itron (ITRI), Cognex (CGNX), OSI Systems (OSIS), Senseonics (SENS), and Hurco Companies (HURC). Mesa Laboratories vs. Its Competitors FARO Technologies Daktronics Vishay Precision Group Coherent Badger Meter Itron Cognex OSI Systems Senseonics Hurco Companies Mesa Laboratories (NASDAQ:MLAB) and FARO Technologies (NASDAQ:FARO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk. Is MLAB or FARO more profitable? FARO Technologies has a net margin of -1.87% compared to Mesa Laboratories' net margin of -104.92%. Mesa Laboratories' return on equity of 30.23% beat FARO Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Mesa Laboratories-104.92% 30.23% 10.43% FARO Technologies -1.87%-2.49%-1.32% Do institutionals & insiders believe in MLAB or FARO? 90.6% of Mesa Laboratories shares are held by institutional investors. Comparatively, 97.2% of FARO Technologies shares are held by institutional investors. 4.4% of Mesa Laboratories shares are held by insiders. Comparatively, 2.4% of FARO Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has preferable earnings and valuation, MLAB or FARO? FARO Technologies has higher revenue and earnings than Mesa Laboratories. FARO Technologies is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMesa Laboratories$240.98M2.37-$254.25M-$0.37-282.46FARO Technologies$341.05M2.40-$56.58M-$0.05-851.00 Does the MarketBeat Community believe in MLAB or FARO? FARO Technologies received 158 more outperform votes than Mesa Laboratories when rated by MarketBeat users. However, 63.82% of users gave Mesa Laboratories an outperform vote while only 63.14% of users gave FARO Technologies an outperform vote. CompanyUnderperformOutperformMesa LaboratoriesOutperform Votes22463.82% Underperform Votes12736.18% FARO TechnologiesOutperform Votes38263.14% Underperform Votes22336.86% Which has more volatility and risk, MLAB or FARO? Mesa Laboratories has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, FARO Technologies has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500. Does the media prefer MLAB or FARO? In the previous week, FARO Technologies had 1 more articles in the media than Mesa Laboratories. MarketBeat recorded 6 mentions for FARO Technologies and 5 mentions for Mesa Laboratories. FARO Technologies' average media sentiment score of 1.24 beat Mesa Laboratories' score of 1.05 indicating that FARO Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mesa Laboratories 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FARO Technologies 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer MLAB or FARO? Mesa Laboratories presently has a consensus price target of $130.00, indicating a potential upside of 24.39%. FARO Technologies has a consensus price target of $35.50, indicating a potential downside of 16.57%. Given Mesa Laboratories' higher probable upside, equities research analysts clearly believe Mesa Laboratories is more favorable than FARO Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mesa Laboratories 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00FARO Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryFARO Technologies beats Mesa Laboratories on 10 of the 17 factors compared between the two stocks. Get Mesa Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLAB vs. The Competition Export to ExcelMetricMesa LaboratoriesProcess control instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$569.27M$18.78B$5.57B$8.63BDividend Yield0.62%0.85%5.28%4.18%P/E Ratio-2.2626.9327.1420.06Price / Sales2.374.44411.98157.10Price / Cash2.5118.5038.2534.64Price / Book3.663.537.064.70Net Income-$254.25M$492.30M$3.23B$247.88M7 Day Performance4.73%1.69%2.85%2.63%1 Month Performance-18.35%-0.47%9.06%6.36%1 Year Performance9.53%-4.31%31.43%14.05% Mesa Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLABMesa Laboratories2.5941 of 5 stars$104.51+0.2%$130.00+24.4%+9.3%$569.27M$240.98M-2.26680High Trading VolumeFAROFARO Technologies1.7349 of 5 stars$42.41+0.1%$35.50-16.3%+133.7%$815.38M$341.05M-121.171,490Positive NewsDAKTDaktronics4.7644 of 5 stars$13.17-11.3%$26.00+97.4%+23.5%$657.09M$799.81M52.682,480Positive NewsHigh Trading VolumeVPGVishay Precision Group1.7176 of 5 stars$25.10-2.4%$28.50+13.5%-17.5%$332.75M$297.48M33.922,700Positive NewsCOHRCoherent4.0965 of 5 stars$76.78+1.5%$101.00+31.5%+21.7%$11.94B$5.60B-187.2723,700BMIBadger Meter3.2077 of 5 stars$252.02+1.5%$229.80-8.8%+32.1%$7.42B$852.49M59.581,980Positive NewsITRIItron3.7294 of 5 stars$116.46+0.7%$127.36+9.4%+15.2%$5.31B$2.44B23.865,480Positive NewsInsider TradeCGNXCognex4.9548 of 5 stars$29.68-1.0%$39.17+32.0%-29.2%$4.98B$919.75M48.662,440Analyst ForecastAnalyst RevisionOSISOSI Systems3.527 of 5 stars$217.48-0.7%$228.33+5.0%+75.4%$3.65B$1.69B27.996,300SENSSenseonics2.3586 of 5 stars$0.53+1.2%$1.55+192.5%+27.4%$346.67M$23.68M-4.0890Positive NewsHURCHurco Companies1.1791 of 5 stars$14.39-1.6%N/A-14.8%$93.31M$187.94M-5.62740Earnings ReportShort Interest ↓ Related Companies and Tools Related Companies FARO Alternatives DAKT Alternatives VPG Alternatives COHR Alternatives BMI Alternatives ITRI Alternatives CGNX Alternatives OSIS Alternatives SENS Alternatives HURC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MLAB) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesa Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesa Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLAB Stock Free MLAB Stock Alerts